Interferon prophylaxis of hepatic carcinoma.
The present article reveals the importance of hepatic carcinoma among the other diseases in digestive oncology, and also the importance of a correct designation of these cases. Epidemiology and actual hypothesis on the mechanisms of oncogenesis are discussed. There are reviewed some studies in the literature concerning infection with hepatitis B virus, hepatitis C virus, coinfection (B and C viruses, B and D viruses), the role of interferon prophylaxis in such cases. Also there is present a statistics on chronic viral hepatits, cirrhosis of viral etiology and hepatic carcinoma, diagnosed in patients in "N.Gh.Lupu" Hospital, over two decades.
Voiosu
R
R
N. Gh. Lupu Hospital, Department of Gastroenterology 19-21, Sos. Stefan cel Mare, 72202 Bucharest, Romania.
Dimitriu
L
L
Dragomir
P
P
Eremia
L
L
D002277:Carcinoma / Q000517:prevention & control* / Q000821:virology; D006525:Hepatitis, Viral, Human / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000517:prevention & control* / Q000821:virology
D007372:Interferons